<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:45:47Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3458558" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3458558</identifier><datestamp>2012-09-27</datestamp><setSpec>nar</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
      <journal-id journal-id-type="publisher-id">nar</journal-id>
      <journal-id journal-id-type="hwp">nar</journal-id>
      <journal-title-group>
        <journal-title>Nucleic Acids Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0305-1048</issn>
      <issn pub-type="epub">1362-4962</issn>
      <publisher>
        <publisher-name>Oxford University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3458558</article-id>
      <article-id pub-id-type="pmcid">PMC3458558</article-id>
      <article-id pub-id-type="pmc-uid">3458558</article-id>
      <article-id pub-id-type="pmid">22735700</article-id>
      <article-id pub-id-type="doi">10.1093/nar/gks614</article-id>
      <article-id pub-id-type="publisher-id">gks614</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Structural Biology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure and activity of the only human RNase T2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Thorn</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Steinfeld</surname>
            <given-names>Robert</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ziegenbein</surname>
            <given-names>Marc</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grapp</surname>
            <given-names>Marcel</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hsiao</surname>
            <given-names>He-Hsuan</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Urlaub</surname>
            <given-names>Henning</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sheldrick</surname>
            <given-names>George M.</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GÃ¤rtner</surname>
            <given-names>Jutta</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="gks614-COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KrÃ¤tzner</surname>
            <given-names>Ralph</given-names>
          </name>
          <xref ref-type="aff" rid="gks614-AFF1">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="gks614-COR1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="gks614-AFF1"><sup>1</sup>Department of Structural Chemistry, <sup>2</sup>Department of Pediatrics and Pediatric Neurology, University of GÃ¶ttingen, <sup>3</sup>Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry and <sup>4</sup>Department of Clinical Chemistry, University of GÃ¶ttingen, 37075 GÃ¶ttingen, Germany</aff>
      <author-notes>
        <corresp id="gks614-COR1">*To whom correspondence should be addressed. Tel: <phone>+49 551 39 8035</phone>; Fax: <fax>+49 551 39 6252</fax>; Email: <email>paediatrie2@med.uni-goettingen.de</email></corresp>
        <corresp>Correspondence may also be addressed to Ralph KrÃ¤tzner. Tel: <phone>+49 551 39 13657</phone>; Fax: <fax>+49 551 39 6236</fax>; Email: <email>rkraetz@gwdg.de</email></corresp>
      </author-notes>
      <!--For NAR both ppub and collection dates generated for PMC processing 1/27/05 beck-->
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>6</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>6</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>40</volume>
      <issue>17</issue>
      <fpage>8733</fpage>
      <lpage>8742</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>30</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author(s) 2012. Published by Oxford University Press.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Mutations in the gene of human RNase T2 are associated with white matter disease of the human brain. Although brain abnormalities (bilateral temporal lobe cysts and multifocal white matter lesions) and clinical symptoms (psychomotor impairments, spasticity and epilepsy) are well characterized, the pathomechanism of RNase T2 deficiency remains unclear. RNase T2 is the only member of the Rh/T2/S family of acidic hydrolases in humans. In recent years, new functions such as tumor suppressing properties of RNase T2 have been reported that are independent of its catalytic activity. We determined the X-ray structure of human RNase T2 at 1.6âÃ resolution. The Î±+Î² core fold shows high similarity to those of known T2 RNase structures from plants, while, in contrast, the external loop regions show distinct structural differences. The catalytic features of RNase T2 in presence of bivalent cations were analyzed and the structural consequences of known clinical mutations were investigated. Our data provide further insight into the function of human RNase T2 and may prove useful in understanding its mode of action independent of its enzymatic activity.</p>
      </abstract>
      <counts>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body><sec><title>INTRODUCTION</title><p>RNase T2 is the only member of the Rh/T2/S family of acidic hydrolases in humans. We recently found that mutations in the RNase T2 gene are associated with white matter disease of human brain that manifests in early infancy (<xref ref-type="bibr" rid="gks614-B1">1</xref>). Affected patients are diagnosed with cystic leukoencephalopathy and show psychomotor retardation, spasticity and epilepsy. Comparable brain abnormalities were also described for a transgenic zebrafish model deficient in RNase T2 activity (<xref ref-type="bibr" rid="gks614-B2">2</xref>). Although the pathomechanism of RNase T2-deficient cystic leukoencephalopathy is still unclear, associated brain magnetic resonance imaging patterns of affected patients are very similar to those of children suffering from an intrauterine infection with cytomegalovirus (CMV). To counteract cellular antiviral mechanisms, CMV inactivates the endoribonuclease RNase L, which is regulated up on viral infections and stops viral protein synthesis by messenger RNA (mRNA) and ribosomal RNA (rRNA) degradation (<xref ref-type="bibr" rid="gks614-B3">3</xref>). RNase T2 therefore might play a similar role as RNase L in cellular immune response processes, and studies on parasitic worm eggs support this hypothesis: the RNase T2 homologous omega-1, secreted by eggs of the blood fluke <italic>Schistosoma mansoni</italic>, triggers a host T helper 2 (Th2) cell-polarized immune response followed by worm egg excretion to start new cycles of parasite infection (<xref ref-type="bibr" rid="gks614-B4">4</xref>,<xref ref-type="bibr" rid="gks614-B5">5</xref>).</p><p>T2 endoribonucleases can also be involved in phosphate scavenging processes. EcRNase 1 is present in the periplasm of <italic>Escherichia coli</italic> and recruits environmental RNA nucleotides (<xref ref-type="bibr" rid="gks614-B6">6</xref>). On phosphate starvation in tomato plants, ribonuclease LE is expressed at a higher rate and extracellular ribonuclease activity is increased (<xref ref-type="bibr" rid="gks614-B7">7</xref>,<xref ref-type="bibr" rid="gks614-B8">8</xref>). RNS2, a T2 endoribonuclease from <italic>Arabidopsis thaliana</italic>, is important for rRNA decay in plant vacuoles and endoplasmic reticulum-derived compartments (<xref ref-type="bibr" rid="gks614-B9">9</xref>).</p><p>RNase T2 proteins can modulate cellular functions independently of their catalytic function. Actibind, a T2 ribonuclease from fungus <italic>Aspergillus niger</italic>, showed an anticlonogenic, tumor suppressing effect even when its catalytic activity was inactivated (<xref ref-type="bibr" rid="gks614-B10">10</xref>,<xref ref-type="bibr" rid="gks614-B11">11</xref>). There is also evidence that human RNase T2 acts as a tumor suppressor. In ovarian cancer cell line Hey3Met2, RNase T2 showed <italic>in vivo</italic> tumor suppressor activity, and two point mutations that eliminate the catalytic activity of RNase T2 showed no effect on its anti-metastatic properties in Hey3Met2 cells in nude mice experiments (<xref ref-type="bibr" rid="gks614-B12">12</xref>). Control of ovarian tumor genesis by RNase T2 thereby occurs through modification of the cellular microenvironment and induction of immunocompetent cells of the monocyte/macrophage lineage (<xref ref-type="bibr" rid="gks614-B13">13</xref>).</p><p>Interestingly, while a broad range of biological functions has been reported for T2 ribonucleases, the known three-dimensional structures of these enzymes from bacteria, fungi and plants are highly conserved with a typical Î±+Î² core structure (<xref ref-type="bibr" rid="gks614-B14">14</xref>). The protein core consists of a 4â8 strand Î²-sheet and the exterior of the proteinâs tertiary structure is formed by helices.</p><p>To our knowledge, no T2 ribonuclease structures from organisms higher than plants have been determined so far. We therefore conducted a structural analysis of human RNase T2 to reveal potential conformational features that differ from those of known structures and may help to explain RNase T2 functions in higher mammals and consequently its role in human neurological diseases.</p><p>Herein, we report the crystal structure of human RNase T2 at a resolution of 1.6âÃ and compare its features to those of plant homologs; inhibition of RNase T2 by bivalent cations as well as functional consequences of clinical known mutations are also discussed.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>Cell culture medium was purchased from Invitrogen (New York, USA). Oligonucleotides for the introduction of the C-terminal tag were synthesized by MWG-Biotech (Munich, Germany). All reagents were purchased from Sigma-Aldrich (Seelze, Germany), unless otherwise indicated.</p><sec><title>Expression of RNase T2</title><p>The amino acid sequence âHHHHHâ was introduced at the C terminus of the RNase T2 to facilitate purification. Transfection of the modified RNase T2 complementary DNA (cDNA) and selection of HEK 293 cells were performed as described previously (<xref ref-type="bibr" rid="gks614-B1">1</xref>,<xref ref-type="bibr" rid="gks614-B15">15</xref>). To produce RNase T2 with predominantly mannose-type glycosylation sites by Î±-mannosidase inhibition for later EndoH treatment, cells were grown with kifunensine (Biomol, Hamburg, Germany) (1âmg/l medium). RNase T2 was purified from the cell culture supernatant (100âml total volume). The medium was cleared by centrifugation at 3000<italic>g</italic> and 4Â°C for 60âmin and then filtered with a 0.2â-Âµm pore membrane. After adding 20âmM K<sub>2</sub>HPO<sub>4</sub>, pH 7.5, 0.5âM NaCl and 40âmM imidazole, the crude solution was loaded on a HisTrap HP column (GE Healthcare, Munich, Germany). Bound RNase T2 was eluted with an imidazole gradient and was typically released at 70â90âmM imidazole. For deglycosylation, the purified RNase T2 fractions were pooled and concentrated using a centrifugal filter (Millipore, Schwalbach, Germany).</p></sec><sec><title>Deglycosylation of RNase T2 and gel filtration</title><p>For cleavage of high mannose oligosaccharides in the N-linked glycoprotein, 88âÎ¼l of concentrated protein solution (10âÂµg/Âµl) from HisTrap were digested with 2âÎ¼l EndoH (New England Biolabs, Frankfurt, Germany) (C: 1000âu/ml) in 10âÎ¼l NEB G5 Buffer for 4âh at 37Â°C leaving one <italic>N</italic>-acetyl glucosamine residue at each of the <italic>N</italic>-glycosylation sites.</p><p>To remove remaining glycosylated protein after digestion in the sample, affinity chromatography with a GE Healthcare 1âml ConA column (flow rate 0.1âml/min, Buffer A: 20âmM TrisâHCl, pH 7.5, 0.5âM NaCl, 1âmM MnCl<sub>2</sub> and 1âmM CaCl<sub>2</sub>, Buffer B: 0.5âM Methyl-Î±-<sc>d</sc>-glucopyranoside, 20âmM TrisâHCl, pH 7.5 and 0.5âM NaCl) was applied. Again, the protein was concentrated to a volume of 700âÂµl. Finally, the protein was gel filtrated using a SuperDex 75 column (flow rate 0.2âml/min, buffer: 200âmM acetate, pH 6.0 and 50âmM NaCl, injection volume 100âÂµl) and could be eluted as a single peak. It was concentrated as before and rebuffered in 20âmM acetate pH 6.0 and 20âmM NaCl. The final concentration was 9.2âmg/ml.</p></sec><sec><title>Mass spectrometry</title><p>Both glycosylated and deglycosylated RNase T2 were reduced with 50âmM dithiothreitol, alkylated with 100âmM 2-chloroacetamide incubated with trypsin (Promega GmbH, Mannheim, Germany) at an enzyme-to-substrate ratio of 1:20 overnight at 37Â°C and analyzed by electrospray ionization liquid chromatography tandem mass spectrometry (LC-MS/MS). The LC-MS/MS analysis was done on an LTQ Orbitrap Velos (Thermo Fisher Scientific, Germany). An extensive description of mass spectrometry analysis methods and results is provided in the <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks614/DC1">Supplementary Material</ext-link>.</p></sec><sec><title>Crystallization</title><p>Hanging drop crystallization was set up on VDXm pre-greased plates (Hampton Research, Aliso Viejo, USA) (0.6âml reservoir) with MD CrystalClene cover slips holding a 2âÎ¼l drop of a 1:1 reservoir/protein solution. A block-shaped crystal (diameter 50âÎ¼m) was grown from microcrystalline and viscous precipitate that had formed in a condition of 0.2âM NH<sub>4</sub>NO<sub>3</sub> (p.a. Merck, Darmstadt, Germany), 15% polyethylene glycol 3350 (Hampton Research) and water after 9 weeks. For cryoprotection, the crystals were soaked in a mixture of glucose (99% purity, Merck)/reservoir solution 1:2 (wt/vol). They were mounted on MiTeGen MicroMounts and flash cooled by plunging into liquid nitrogen.</p></sec><sec><title>Data collection and processing</title><p>Datasets were measured at BESSY MX 14.1 beam line with a Rayonix MX-225 3âÃâ3 CCD detector. Data collection statistics for three native datasets are summarized in <xref ref-type="table" rid="gks614-T1">Table 1</xref>. Statistics for an additional long-wavelength dataset can be found in the <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks614/DC1">Supplementary Material</ext-link>. The crystals belonged to the monoclinic space group P2<sub>1</sub>, a typical space group for T2 RNases (<xref ref-type="bibr" rid="gks614-B16">16</xref>). The data were integrated with XDS (<xref ref-type="bibr" rid="gks614-B17">17</xref>), converted with XDS2SAD for absorption correction with SADABS (<xref ref-type="bibr" rid="gks614-B18">18</xref>). XPREP (<xref ref-type="bibr" rid="gks614-B19">19</xref>) was used for merging and data quality analysis.
<table-wrap id="gks614-T1" position="float"><label>Table 1.</label><caption><p>Summary of the collection statistics</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Source</th><th colspan="3" rowspan="1">BESSY MX 14.1</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Unit cell dimensions</td><td colspan="3" rowspan="1"><italic>a</italic>â=â31.322, <italic>b</italic>â=â68.092, <italic>c</italic>â=â47.984, <italic>Î²</italic>â=â90.827Â°</td></tr><tr><td rowspan="1" colspan="1">Space group</td><td colspan="3" rowspan="1">P2<sub>1</sub></td></tr><tr><td rowspan="1" colspan="1">Wavelength (Ã)</td><td rowspan="1" colspan="1">0.9184</td><td rowspan="1" colspan="1">0.9184</td><td rowspan="1" colspan="1">0.9810</td></tr><tr><td rowspan="1" colspan="1">Oscillation range</td><td rowspan="1" colspan="1">95Â°</td><td rowspan="1" colspan="1">103.5Â°</td><td rowspan="1" colspan="1">237Â°</td></tr><tr><td rowspan="1" colspan="1">Resolution range (Ã)</td><td rowspan="1" colspan="1">27.56â1.73 (1.83â1.73)</td><td rowspan="1" colspan="1">28.31â1.74 (1.84â1.74)</td><td rowspan="1" colspan="1">28.31â1.59 (1.69â1.59)</td></tr><tr><td rowspan="1" colspan="1">Number of observations</td><td rowspan="1" colspan="1">40â334 (5303)</td><td rowspan="1" colspan="1">43â694 (6281)</td><td rowspan="1" colspan="1">75â521 (11â987)</td></tr><tr><td rowspan="1" colspan="1">Unique<xref ref-type="table-fn" rid="gks614-TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">20â100 (2714)</td><td rowspan="1" colspan="1">20â030 (2926)</td><td rowspan="1" colspan="1">26â238 (4246)</td></tr><tr><td rowspan="1" colspan="1">Redundancy<xref ref-type="table-fn" rid="gks614-TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">1.96 (1.73)</td><td rowspan="1" colspan="1">2.13 (1.94)</td><td rowspan="1" colspan="1">2.80 (2.55)</td></tr><tr><td rowspan="1" colspan="1">Completeness<xref ref-type="table-fn" rid="gks614-TF1"><sup>a</sup></xref> (%)</td><td rowspan="1" colspan="1">97.5 (88.6)</td><td rowspan="1" colspan="1">97.7 (90.5)</td><td rowspan="1" colspan="1">97.2 (90.3)</td></tr><tr><td rowspan="1" colspan="1">Mean <italic>I</italic>/<italic>Ï</italic> (I)</td><td rowspan="1" colspan="1">17.00 (4.11)</td><td rowspan="1" colspan="1">20.47 (6.48)</td><td rowspan="1" colspan="1">16.74 (5.04)</td></tr><tr><td rowspan="1" colspan="1"><italic>R</italic><sub>int</sub> (%)</td><td rowspan="1" colspan="1">3.06 (19.54)</td><td rowspan="1" colspan="1">2.63 (13.59)</td><td rowspan="1" colspan="1">3.07 (19.10)</td></tr><tr><td rowspan="1" colspan="1"><italic>R</italic><sub>rim</sub> (%)</td><td rowspan="1" colspan="1">4.15 (26.80)</td><td rowspan="1" colspan="1">3.45 (17.83)</td><td rowspan="1" colspan="1">3.75 (23.38)</td></tr><tr><td rowspan="1" colspan="1"><italic>R</italic><sub>pim</sub> (%)</td><td rowspan="1" colspan="1">2.79 (18.25)</td><td rowspan="1" colspan="1">2.21 (11.44)</td><td rowspan="1" colspan="1">2.11 (13.31)</td></tr></tbody></table><table-wrap-foot><fn id="gks614-TF1"><p>The three datasets were merged for structure solution and refinement. Values in parentheses refer to outer shell.</p></fn><fn id="gks614-TF2"><p><sup>a</sup>Friedel pairs merged.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Structure solution and refinement</title><p>For structure solution, the unmodified protein molecule of RNase LE (<xref ref-type="bibr" rid="gks614-B20">20</xref>) was used as search model. The correct PHASER (<xref ref-type="bibr" rid="gks614-B21">21</xref>) solution was identified and improved by density modification and subsequent poly-Ala tracing with SHELXE (<xref ref-type="bibr" rid="gks614-B22">22</xref>). In a SHELXE âfree lunchâ map extended to 1.0âÃ resolution, the initial model with 178 residues was built from the poly-Ala backbone using COOT (<xref ref-type="bibr" rid="gks614-B23">23</xref>). The structure was refined with REFMAC (<xref ref-type="bibr" rid="gks614-B24">24</xref>).</p><p>After checking with the TLS-MD server (<xref ref-type="bibr" rid="gks614-B25">25</xref>), TLS refinement (<xref ref-type="bibr" rid="gks614-B26">26</xref>) was applied, with only one domain consisting of the whole enzyme. Checks with WHATIF (<xref ref-type="bibr" rid="gks614-B27">27</xref>) as well as with MOLPROBITY (<xref ref-type="bibr" rid="gks614-B28">28</xref>) lead to a significant improvement of the model.</p><p>The REFMAC weighting scheme was optimized. Refinement statistics are given in <xref ref-type="table" rid="gks614-T2">Table 2</xref>. The sulfur positions were confirmed using the anomalous dataset and the program ANODE (<xref ref-type="bibr" rid="gks614-B29">29</xref>). Using the SSM web service (<xref ref-type="bibr" rid="gks614-B30">30</xref>), no significant intermolecular contact surface could be found, so the molecules appear to be biological monomers. Topological analysis of the protein was performed with PDBsum (<xref ref-type="bibr" rid="gks614-B31">31</xref>).
<table-wrap id="gks614-T2" position="float"><label>Table 2.</label><caption><p>Summary of the refinement statistics</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th colspan="2" rowspan="1">Refinement statistics</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Resolution range</td><td rowspan="1" colspan="1">27.56â1.59</td></tr><tr><td rowspan="1" colspan="1">Number of reflections in working set</td><td rowspan="1" colspan="1">25â064</td></tr><tr><td rowspan="1" colspan="1">Completeness of the working set</td><td rowspan="1" colspan="1">98.00</td></tr><tr><td rowspan="1" colspan="1">Number of reflections in test set</td><td rowspan="1" colspan="1">1347</td></tr><tr><td rowspan="1" colspan="1">Solvent content (%)</td><td rowspan="1" colspan="1">43.99</td></tr><tr><td rowspan="1" colspan="1">Number of protein atoms</td><td rowspan="1" colspan="1">1642</td></tr><tr><td rowspan="1" colspan="1">Number of water molecules</td><td rowspan="1" colspan="1">182</td></tr><tr><td rowspan="1" colspan="1">Protein molecules per ASU</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1"><italic>R</italic> (%)</td><td rowspan="1" colspan="1">15.38</td></tr><tr><td rowspan="1" colspan="1"><italic>R</italic><sub>free</sub> (%)</td><td rowspan="1" colspan="1">19.03</td></tr><tr><td rowspan="1" colspan="1">Average B factors (Ã<sup>2</sup>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ââââOverall</td><td rowspan="1" colspan="1">18.89</td></tr><tr><td rowspan="1" colspan="1">ââââProtein atoms</td><td rowspan="1" colspan="1">18.27</td></tr><tr><td rowspan="1" colspan="1">ââââWater molecules</td><td rowspan="1" colspan="1">21.93</td></tr><tr><td rowspan="1" colspan="1">Observed r.m.s.d. from ideal geometry<xref ref-type="table-fn" rid="gks614-TF2"><sup>a</sup></xref></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ââââBond lengths (Ã)</td><td rowspan="1" colspan="1">0.021</td></tr><tr><td rowspan="1" colspan="1">ââââBond angles (Â°)</td><td rowspan="1" colspan="1">1.057</td></tr><tr><td rowspan="1" colspan="1">Ramachandran plot, residues in<xref ref-type="table-fn" rid="gks614-TF3"><sup>b</sup></xref></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ââââFavored regions</td><td rowspan="1" colspan="1">97.37</td></tr><tr><td rowspan="1" colspan="1">ââââAllowed regions</td><td rowspan="1" colspan="1">2.63</td></tr></tbody></table><table-wrap-foot><fn id="gks614-TF3"><p>Values in parentheses refer to the outer shell.</p></fn><fn id="gks614-TF4"><p><sup>a</sup>REFMAC output.</p></fn><fn id="gks614-TF5"><p><sup>b</sup>Calculated with MOLPROBITY.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Zinc binding site calculation</title><p>Potential zinc binding sites were recognized by the FEATURE metal scanning server (<xref ref-type="bibr" rid="gks614-B32">32</xref>) using default options; hits above a <italic>Z</italic>-score threshold of 20.0 were assessed.</p></sec><sec><title>Computer graphics</title><p>Figures of human RNase T2 were produced with the program PyMOL (PYMOL molecule rendering; DeLano Scientific, Palo Alto, USA) (<xref ref-type="bibr" rid="gks614-B33">33</xref>).</p></sec><sec><title>RNase activity assay</title><p>RNase activity assays were performed as previously described (<xref ref-type="bibr" rid="gks614-B1">1</xref>). Enzymatic activity toward yeast RNA was measured in terms of the increase in absorbance at 260ânm due to soluble nucleotide production after digestion at 37Â°C of substrate at pH 4.6 or 6.0, respectively. Briefly, 1âÂµl of a stock solution containing 4.5âÎ¼g/Âµl of RNase T2 was added on ice to a reaction mix containing RNA at a concentration of 4âmg/ml buffer (0.2âM sodium acetate and 0.05âM NaCl, pH 4.6 or 6.0) in a total volume of 400âÎ¼l. Blank tubes were prepared in the same way, except that the RNase T2 was replaced by buffer solution. As a control, half of the reaction mixture was precipitated immediately. The remaining 200âÎ¼l of the reaction mixture was incubated for 30âmin at 37Â°C and then 50âÎ¼l of stop mixture (0.75% (wt/vol) uranyl acetate in 25% (vol/vol) perchloric acid) was added. The reaction mixture was cooled on ice for 15âmin and centrifuged at 14â000<italic>g</italic> for 15âmin at 4Â°C to remove precipitated RNA. Fifty microliters of the supernatant fluid containing the free nucleotides were diluted 40-fold with distilled water, and absorbance determined at 260ânm. To analyze the effect of bivalent metal ions on RNase T2 activity, stock solutions of RNase T2 containing 2.25âÂµg/Âµl of enzyme and 5 or 50âmM of Zn<sup>2+</sup>, Cu<sup>2+</sup>, Co<sup>2+</sup>, Ni<sup>2+</sup> or Mg<sup>2+</sup> were prepared. After 2âh of incubation at 37Â°C, 2âÂµl of stock solution was applied in activity assays as described above, the activity was measured in comparison to equal amounts of untreated enzyme. To examine the effect of ethylenediaminetetraacetic acid (EDTA), 20âÂµl of the RNase T2 solution pretreated with 50âmM Zn<sup>2+</sup> where mixed with 20âÂµl of 100âmM ETDA, 0.2âM sodium acetate and 0.05âM NaCl at pH 6.0. After incubation for 30âmin at 37Â°C, 4âÂµl of this mixture was measured for activity as described above in comparison to equal amounts of untreated enzyme.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>This is the first structure determination to be reported for human RNase T2.</p><sec><title>Quality of the structure</title><p>The structure of human RNase T2 has been determined by X-ray diffraction from crystals in the monoclinic space group P2<sub>1</sub> at a resolution of 1.6âÃ. Data collection and refinement statistics are shown in <xref ref-type="table" rid="gks614-T1">Tables 1</xref> and <xref ref-type="table" rid="gks614-T2">2</xref>. The structural refinement of human RNase T2 converged to an <italic>R</italic><sub>free</sub> of 19.03% and an <italic>R</italic>-value of 15.39%. The overall geometry shows no abnormalities, with an all-atom clash score of 5.97 and 0.6% bad rotamers as given by MOLPROBITY (<xref ref-type="bibr" rid="gks614-B23">23</xref>). The structure had no outliers and 97.4% of all residues were in the favored regions of the Ramachandran plot.</p></sec><sec><title>Overall structure and fold</title><p>Human RNase T2 crystallizes, like almost all other T2 RNases, with one monomer in the asymmetric unit, which also comprises the biological active unit.</p><p>The structure shows a typical fold for members of the T2 RNase family with seven Î±-helices and eight Î²-strands constituting an Î±+Î² motif (<xref ref-type="bibr" rid="gks614-B34">34</xref>), as most of the central anti-parallel Î²-sheet is clearly separated in the sequence from the helical parts (<xref ref-type="fig" rid="gks614-F1">Figures 1</xref> and <xref ref-type="fig" rid="gks614-F2">2</xref>). The central Î²-sheet consists of six strands (Î²1â2, Î²4â7) and is flanked by a large helical region containing Î±-helices Î±1â4. The 15-residue long Î±-helix 5 runs across the central Î²-sheet and is joined by a three amino acid linker with Î±-helix 6; Î±7 flanks the central Î²-sheet opposite the region containing helices Î±1âÎ±4. The two Î²-strands Î²3 and Î²8 form a small sheet at the bottom of the protein. Most of the annotated catalytic residues are located in a distorted helix region consisting of residues 110â121 (Î±3, Î±4). The catalytic site was annotated by comparison with homologous structures and comprises residues His 65, His 113, Glu 114, Lys 117 and His 118 (see âDiscussionâ section).
<fig id="gks614-F1" position="float"><label>Figure 1.</label><caption><p>The sequence of human RNase T2. The first 24 residues correspond to a signal peptide, which is cleaved. Î²-strands are marked with red arrows and Î±-helices with dark blue barrels. Gray residues are not visible in the electron density; the other colors refer to <xref ref-type="fig" rid="gks614-F2">Figure 2</xref>.</p></caption><graphic xlink:href="gks614f1"/></fig>
<fig id="gks614-F2" position="float"><label>Figure 2.</label><caption><p>The structure shows a typical Î±+Î² core fold. The catalytic residues are shown as sticks. (<bold>A</bold>) Topology of human RNase T2: the structure shows the typical fold of this family with seven Î±-helices and eight Î²-strands compromising two anti-parallel sheets. (<bold>B</bold>) Residues 188â192 and 214â235 and the terminal ends are disordered and could not be resolved in the electron density. Disulfide bridges are shown in green. The box refers to <xref ref-type="fig" rid="gks614-F6">Figure 6</xref>.</p></caption><graphic xlink:href="gks614f2"/></fig></p><p>Human RNase T2 has four disulfide bridges, connecting cysteine residues 48/55, 75/121, 184/241 and 202/213, which can also be found in the nearest structural relatives (<xref ref-type="table" rid="gks614-T3">Table 3</xref>). No model could be built for residues 188â192 and 214â235 as well as the terminal ends as they were disordered.
<table-wrap id="gks614-T3" position="float"><label>Table 3.</label><caption><p>Structural alignment statistics, as given by SSM Tool (<xref ref-type="bibr" rid="gks614-B30">30</xref>)</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Name</th><th rowspan="1" colspan="1">PDB</th><th rowspan="1" colspan="1">Residues</th><th rowspan="1" colspan="1">Sequence identity (%)</th><th rowspan="1" colspan="1">r.m.s.d. (Ã)</th><th rowspan="1" colspan="1">Color as in <xref ref-type="fig" rid="gks614-F5">Figure 5</xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">RNase LE</td><td rowspan="1" colspan="1">1DIX</td><td rowspan="1" colspan="1">208</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">1.50</td><td rowspan="1" colspan="1">Gray</td></tr><tr><td rowspan="1" colspan="1">RNase MC1<xref ref-type="table-fn" rid="gks614-TF4"><sup>a</sup></xref></td><td rowspan="1" colspan="1">1UCG</td><td rowspan="1" colspan="1">190</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">1.61</td><td rowspan="1" colspan="1">Pale cyan</td></tr><tr><td rowspan="1" colspan="1">RNase MC1</td><td rowspan="1" colspan="1">1BK7</td><td rowspan="1" colspan="1">190</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">1.59</td><td rowspan="1" colspan="1">Not shown</td></tr><tr><td rowspan="1" colspan="1">RNase NW, chain B</td><td rowspan="1" colspan="1">1IYB</td><td rowspan="1" colspan="1">208</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">1.66</td><td rowspan="1" colspan="1">Light gray</td></tr></tbody></table><table-wrap-foot><fn id="gks614-TF6"><p><sup>a</sup>For the figure, the mutant N71T was chosen as the structure shows a slightly lower r.m.s.d. with our protein than the wild type. All r.m.s.d. values are in comparison to RNase T2, but only for the compared sequence part.</p></fn></table-wrap-foot></table-wrap></p><p>Mass spectrometry of the wild-type protein reveals three glycosylation sites at asparagine residues 76, 106 and 212. Two bound <italic>N</italic>-acetyl glucosamine residues left over from the EndoH deglycosylation are clearly visible in the electron density at Asn 76 and Asn 212. Asn 106 does not have corresponding electron density in its vicinity, which might be because of disorder or carbohydrate cleavage.</p></sec><sec><title><italic>In silico</italic> analysis of potential zinc binding sites</title><p>Furthermore, investigation of the structure revealed a well-established water position directly behind the catalytic site between residues His 65, Tyr 42 and Gln 198 that showed some properties of a zinc binding site. For RNase T2 from <italic>Aspergillus oryzae</italic>, zinc and copper ions were reported to be potent inhibitors of catalytic hydrolase activity (<xref ref-type="bibr" rid="gks614-B35">35</xref>,<xref ref-type="bibr" rid="gks614-B36">36</xref>). We therefore performed an <italic>in silico</italic> prediction of potential zinc binding sites in human RNase T2 and analyzed the effect of bivalent metal ions on RNase T2 catalysis in activity assays. A number of potential zinc binding positions were predicted with the FEATURE (<xref ref-type="bibr" rid="gks614-B32">32</xref>) web server. The <italic>Z</italic>-score threshold of the potential zinc binding sites was between 20.0 and 27.7 and clustered in three sites (<xref ref-type="fig" rid="gks614-F3">Figure 3</xref>):
<list list-type="simple"><list-item><label>(1)</label><p>eight hits between the residues Trp 68, His 118 and Glu 114;</p></list-item><list-item><label>(2A)</label><p>four hits between the residues His 65, Glu 198 and His 42, forming a 2-histidine-1-carboxylate motif;</p></list-item><list-item><label>(2B)</label><p>two hits between His 42, His 65 and the carbonyl group of Ile 64.</p></list-item></list>
<fig id="gks614-F3" position="float"><label>Figure 3.</label><caption><p>The potential zinc binding sites predicted by the FEATURE web server (<xref ref-type="bibr" rid="gks614-B32">32</xref>). Site 1 is colored in yellow, 2A in green and 2B in cyan; the involved residues are labeled. While the dashed lines refer to potential bonds, the residues will most likely change conformation to accommodate the metal coordination.</p></caption><graphic xlink:href="gks614f3"/></fig></p><p>Site 1 corresponds approximately to the binding site of phosphate in the structure of Actibind. Leeuw <italic>et al.</italic> (<xref ref-type="bibr" rid="gks614-B37">37</xref>) also suggested that this site might be important for the catalyzed reaction.</p></sec><sec><title>RNase T2 activity is inhibited by zinc and copper ions but is independent of glycosylation</title><p>Catalytic activity of soluble RNase T2 from <italic>Aspergillus oryzae</italic> has been reported to be reduced by zinc and copper ions (<xref ref-type="bibr" rid="gks614-B35">35</xref>,<xref ref-type="bibr" rid="gks614-B36">36</xref>). For human RNase T2 at pH 6.0, we find that the residual activity in the presence of 5âmM zinc sulfate is only 40% of that of the untreated protein (<xref ref-type="fig" rid="gks614-F4">Figure 4</xref>A); with Cu<sup>2+</sup> ions, the activity was even reduced to 6%. No significant inhibitory effects were measured with equimolar solutions of nickel, cobalt or calcium. If treated with 50âmM bivalent metal ions, no residual enzymatic activity was detectable for zinc and copper, while for cobalt, nickel and magnesium no pronounced reduction in activity was measured. The inhibitory effects of zinc were reversible and could be eliminated by incubation with 100âmM EDTA at 37Â°C for 30âmin (this was not measured for copper).
<fig id="gks614-F4" position="float"><label>Figure 4.</label><caption><p>The activity of RNase T2 was measured under different conditions. All values are means of two independent experiments and uncertainty ranges represent standard deviations. (<bold>A</bold>) At pH 6.0, the effects of several bivalent cations on RNase T2 activity were determined at 5 and 50âmM ion concentration. The activity bars are normalized relative to an untreated control. (<bold>B</bold>) The effects of several bivalent cations on RNase T2 activity were determined at 5 and 50âmM ion concentrations at pH 4.6. At this pH, RNase T2 showed an activity around 4.5 U/Âµg, with one unit defined as the amount of enzyme that produces a change of 1 OD<sub>260</sub> in 30âmin at 37Â°C. All activities are normalized relative to an untreated control. (<bold>C</bold>) The activity of native RNase T2 in comparison to that of deglycosylated RNase T2 at pH 4.6 and 6.0. The activity of the native protein was normalized as 100%. (<bold>D</bold>) The pH dependency of enzymatic activity was measured for native and for deglycosylated RNase T2, with the activity at pH 4.6 normalized to 100%.</p></caption><graphic xlink:href="gks614f4"/></fig></p><p>Since T2 RNases were reported to show their highest activity under more acidic conditions, these experiments were repeated at pH 4.6. Indeed, at pH 4.6, the enzymatic activity was 23% higher than at pH 6.0 for the native protein (<xref ref-type="fig" rid="gks614-F4">Figure 4</xref>D). Although no significant inhibitory effect of cobalt, nickel or magnesium was detectable at 50 mM concentration, equimolar amounts of zinc and copper eliminated enzymatic activity completely (<xref ref-type="fig" rid="gks614-F4">Figure 4</xref>B). The inhibitory effects of zinc and copper at a concentration of 5âmM were found to be similar as to those at pH 6.0.</p><p>As RNase T2 was crystallized after deglycosylation with EndoH, the influence of glycosylation on the enzymatic activity was tested. However, no significant differences could be observed when the <italic>in vitro</italic> activity of untreated RNase T2 was compared with that of EndoH digested protein (<xref ref-type="fig" rid="gks614-F4">Figure 4</xref>C).</p></sec><sec><title>Comparison with other structures and main-chain displacement</title><p>Structural alignment with PDBeFold (SSM) (<xref ref-type="bibr" rid="gks614-B30">30</xref>) was used to identify structural relatives of RNase T2 in the PDB. Six structures related to human RNase T2 derived from three different RNases were investigated: RNase LE from tomato <italic>Solanum lycopersicum</italic> (<xref ref-type="bibr" rid="gks614-B20">20</xref>), Ribonuclease MC from bitter gourd <italic>Momordica charantia</italic> (<xref ref-type="bibr" rid="gks614-B38">38</xref>,<xref ref-type="bibr" rid="gks614-B39">39</xref>) and Ribonuclease NW from <italic>Nicotiana glutinosa</italic> (<xref ref-type="bibr" rid="gks614-B40">40</xref>). A secondary structure matching superposition of all three proteins with human RNase T2 revealed that the core fold is strictly conserved, while the outer loops show conformational differences. Loop 50-57 bends inwards when compared with the other T2 RNases. Human RNase T2 has a beta turn at residues 69â72, while the structural relatives contain a more extended loop at this position.</p><p>In the structures RNase LE, NW and MC, as well as in the recently published structure of Actibind (PDB 3D3Z (<xref ref-type="bibr" rid="gks614-B37">37</xref>)) and even in the more distant structural relative RNase 1 from <italic>E. coli</italic> (PDB code 2Z70 (<xref ref-type="bibr" rid="gks614-B6">6</xref>)), the Î²-sheet 4 is overlaid by a loop region. In human RNase T2, there seems to be a longer, partly disordered (residues 215â234) loop with a different conformation. The primary sequences of the structural relatives differ significantly after cysteine 213 and only residues 240â251 align to the C-terminal region of the other proteins. The displacement of the protein main chain is illustrated as B factor putty in <xref ref-type="fig" rid="gks614-F5">Figure 5</xref>; the width and color of the ribbon correspond to the average B factor of the residues. The structural alignment is shown in this figure and summarized in <xref ref-type="table" rid="gks614-T3">Table 3</xref>.
<fig id="gks614-F5" position="float"><label>Figure 5.</label><caption><p>Overlay of the B factor putty representation of human RNase T2 and three other members of its family: RNase MC1 (1UCG) in pale cyan, RNase Le (1DIX) in gray and RNase NW (1IYB) in light gray. The average displacement, given by the putty, is tightly related to the differences between the structures, suggesting that the rigid part mainly conveys the catalytic function while outer loops adapt. The structures from plant T2 RNases have a prolonged loop between residues 70 and 71. Also, the disordered loop 214â235 (approximate position is painted as a dashed line) seems not to have an equivalent in the other structures, and possibly involves an insertion. Loop 50-57 of RNase T2 bends inwards when compared with the other T2 RNases. Apart from these differences in the outer regions, the core fold is highly conserved and rigid, as can be seen from its low average B factor.</p></caption><graphic xlink:href="gks614f5"/></fig></p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec><title>Catalysis</title><p>RNA cleavage by T2 RNases is mediated by histidine residues in the conserved active site motifs CASI and CASII (<xref ref-type="bibr" rid="gks614-B14">14</xref>). Mutations in these histidine residues lead to inactivation of the enzyme both <italic>in vivo</italic> and <italic>in vitro</italic> (<xref ref-type="bibr" rid="gks614-B16">16</xref>), and zinc has been shown to inhibit the cleavage <italic>in vitro</italic>. Substrate binding involves hydrophobic interactions and hydrogen bonding to the phosphate group (<xref ref-type="bibr" rid="gks614-B16">16</xref>). The substrate binding sites have been identified by co-crystallization with mono- and di-nucleotides (<xref ref-type="bibr" rid="gks614-B20">20</xref>,<xref ref-type="bibr" rid="gks614-B41">41</xref>). In human RNase T2, CASI spans residues 62â69, the aligned CASII spans residues 110â121. The latter motif almost forms a perfect Î±-helix, but the carbonyl groups of residues 116 and 117 do not make proper hydrogen bonds and His 118 has slightly deviant phi and psi angles. This results in a distortion in the helix, possibly allowing for a higher energy state and better mobility of the catalytic residues 117 and 118. Due to the highly conserved geometrical catalytic environment of RNase T2, the enzymatic reaction mechanism is proposed to be analogous to the one postulated by Kurihara <italic>et al</italic>. (<xref ref-type="bibr" rid="gks614-B42">42</xref>). A comparison with the active site of RNase LE (<xref ref-type="bibr" rid="gks614-B20">20</xref>) as well as the reaction mechanism is given in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks614/DC1">Supplementary Figures S1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks614/DC1">S2</ext-link>. The RNA binding surface with relevant residues is modeled in <xref ref-type="fig" rid="gks614-F6">Figure 6</xref>.
<fig id="gks614-F6" position="float"><label>Figure 6.</label><caption><p>Surface of the assumed RNA binding pocket shown with numbered residues. Residue 109 is disordered.</p></caption><graphic xlink:href="gks614f6"/></fig></p></sec><sec><title>Role of zinc</title><p>On visual inspection, we predicted a zinc binding site for RNase T2 in the region of His 65 which was supported by <italic>in silico</italic> analysis of RNase T2 with the FEATURE web server. The program also found a potential zinc binding region in the catalytic cleft of RNase T2, though the enzyme does not require divalent ions as cofactor. Using RNase activity assays, we showed that zinc and also copper inhibit human RNase T2 even at 5âmM concentration. A comparable inhibition by the same metal ions was already reported for RNase T2 from fungus <italic>Aspergillus oryzae.</italic> Despite this, it is uncertain how many zinc or copper ions are involved and whether they bind to distinct regions of human RNase T2. Furthermore, crystallization experiments in the presence of zinc or copper would be needed to clarify this question, but each of the predicted zinc binding regions would readily explain the observed reversible inhibition of the enzyme on treatment with EDTA. It remains unclear whether zinc binding is of physiological relevance. Coordination in Site 2B might also affect the main-chain conformation and hence, influence the shape of the protein surface with potential consequences for proteinâprotein interactions.</p></sec><sec><title>Clinical relevant mutations</title><p>A number of inherited mutations in the gene encoding for RNase T2 are known to be associated with white matter disease of human brain (<xref ref-type="bibr" rid="gks614-B1">1</xref>). Analyzing the role of these mutations using the X-ray structure of RNase T2, almost each one has severe consequences for the proteinâs conformation (<xref ref-type="table" rid="gks614-T4">Table 4</xref>). The point mutation Cys184Arg destroys the disulfide bridge Cys 184âCys 241 which might result in destabilization of the loop in which Cys 241 sits and therefore the lower part of the major Î²-sheet. The remaining unlinked SH group of Cys 241 might promote precipitation and instability. Thus, our structural data underline the disease causing effect of the Cys184Arg mutation of the affected patient.
<table-wrap id="gks614-T4" position="float"><label>Table 4.</label><caption><p>Known mutations in RNase T2 with clinical relevance. (<xref ref-type="bibr" rid="gks614-B1">1</xref>)</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Mutation type</th><th rowspan="1" colspan="1">Affected amino acids</th><th rowspan="1" colspan="1">Comment</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Missense</td><td rowspan="1" colspan="1">Cys184Arg</td><td rowspan="1" colspan="1">Disulfide bridge 184â241 missing, destabilizing and sensitizing for oxidation</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Met 1âGlu 92</td><td rowspan="1" colspan="1">Secretion signal peptide deleted; deletion of central part of Î±+Î² motif containing Î²1, Î²2, Î±1 and Î±2</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Ala 17âLeu 21</td><td rowspan="1" colspan="1">Secretion signal peptide deleted</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Asp 30âTrp 86</td><td rowspan="1" colspan="1">Deletion of central part of Î±+Î² motif containing Î²1, Î²2, Î±1 and Î±2</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Asp 30âTrp 111</td><td rowspan="1" colspan="1">Deletion of central part of Î±+Î² motif containing Î²1, Î²2, Î±1 and Î±2</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Pro 69âTrp 111</td><td rowspan="1" colspan="1">Deletion of central part of Î±+Î² motif containing Î²2 and Î±2</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Val 165âGln 189</td><td rowspan="1" colspan="1">Deletion of central part of Î±+Î² motif containing Î²4 and Î±7</td></tr><tr><td rowspan="1" colspan="1">Stop</td><td rowspan="1" colspan="1">Asp 88âXXâStop</td><td rowspan="1" colspan="1">Rest of protein is not produced</td></tr><tr><td rowspan="1" colspan="1">Stop</td><td rowspan="1" colspan="1">Asp 88âXXXâStop</td><td rowspan="1" colspan="1">Rest of protein is not produced</td></tr></tbody></table></table-wrap></p><p>The other known patient mutations within the RNase T2 gene influence mRNA splicing and result in a variety of large internal deletions that all affect the Î±+Î² core motif.</p></sec><sec><title>Structural differences to other members of the T2 family/TRAF2</title><p>Comparison between human RNase T2 and plant T2 RNases shows that the Î±+Î² core motif is highly conserved with no pronounced deviations between the main-chain atom positions. However, conformational differences were found in parts of the outer loops. Some of these regions could be important for proteinâprotein interactions of RNase T2. It was recently shown that RNase T2 co-localizes with processing (P-) bodies which increase upon metabolic stress and that cells lacking RNase T2 show a reduced number of P-bodies (<xref ref-type="bibr" rid="gks614-B43">43</xref>). It has still to be seen whether or which outer loop regions of RNase T2 are involved in P-body formation. Minor main-chain deviations in surface regions could be due to crystallization conditions, crystal packing or similar effects, but the region between Cys213 and Val240 clearly differs between human RNase T2 and the compared structures. Since no model could be built for that part of the peptide chain, this region is assumed to comprise a highly disordered loop. This loop contains 21 or 22 amino acid residues more than the corresponding ordered regions in RNase LE, Ribonuclease MC and Ribonuclease NW. Analysis of the RNase T2 amino acid sequence between Cys213 and Val240 using the ELM tool for the identification of eukaryotic linear motifs for functional sites in proteins <italic>in silico</italic> (<xref ref-type="bibr" rid="gks614-B44">44</xref>) revealed a potential tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) binding motif, PKQE, at Positions 222â225. TRAF2 plays an important role in cellular signaling for anti-inflammatory and apoptotic response (<xref ref-type="bibr" rid="gks614-B45">45</xref>). TRAF2 binds as an associated factor to the cytosolic domain of TNFÎ± receptor and modulates TNFÎ± action on the MAP kinase and NFÎºB pathway.</p><p>There is evidence that human RNase T2 acts as a tumor suppressor and might be involved in immune response processes (<xref ref-type="bibr" rid="gks614-B4">4</xref>,<xref ref-type="bibr" rid="gks614-B5">5</xref>,<xref ref-type="bibr" rid="gks614-B10 gks614-B11 gks614-B12 gks614-B13">10â13</xref>). In contrast to RNase A homolog Onconase from frog <italic>Rana pipiens</italic>, whose antitumoral activity depends on its ribonucleolytic properties, the tumor suppressive features of RNase T2 seem not to be linked to its catalytic function (<xref ref-type="bibr" rid="gks614-B46">46</xref>). A TRAF2 binding siteâparticularly in a protein region that clearly differs from that of the related plant enzymesâcould be a starting point to explain further functions of RNase T2 independent of its enzymatic activity. However, further experiments are needed to verify the predicted TRAF2 site and to evaluate its physiological relevance.</p></sec></sec><sec><title>ACCESSION NUMBERS</title><p>PDB-ID: 3T0O.</p></sec><sec><title>SUPPLEMENTARY DATA</title><p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks614/DC1">Supplementary Data</ext-link> are available at NAR Online: Supplementary Table 1, Supplementary Figures 1 and 2 and Supplementary Methods and Results.</p></sec><sec><title>FUNDING</title><p><funding-source>German Bundesministerium fÃ¼r Bildung und Forschung (BMBF)</funding-source> [LEUKONET]. Funding for open access charge: <funding-source>BMBF</funding-source>.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplementary Data</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_40_17_8733__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_gks614_nar-00673-h-2012-File008.pdf"/>
</supplementary-material>
</sec>
</body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>We thank Christian Grosse for his support in crystallization and data collection.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="gks614-B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henneke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Diekmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohlenbusch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaiser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Engelbrecht</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kohlschutter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>KrÃ¤tzner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Madruga-Garrido</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Opitz</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection</article-title>
          <source>Nat. Genet.</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>773</fpage>
          <lpage>775</lpage>
          <pub-id pub-id-type="pmid">19525954</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haud</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kara</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Diekmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Henneke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Willer</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hillwig</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Gregg</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Macintosh</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>GÃ¤rtner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alia</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RnaseT2 mutant zebrafish model familial cystic leukoencephalopathy and reveal a role for Rnase T2 in degrading ribosomal RNA</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2011</year>
          <volume>108</volume>
          <fpage>1099</fpage>
          <lpage>1103</lpage>
          <pub-id pub-id-type="pmid">21199949</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Child</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Jarrahian</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Geballe</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus</article-title>
          <source>J. Virol.</source>
          <year>2002</year>
          <volume>76</volume>
          <fpage>4912</fpage>
          <lpage>4918</lpage>
          <pub-id pub-id-type="pmid">11967308</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Everts</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Perona-Wright</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Smits</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Hokke</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>van der Ham</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Fitzsimmons</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Doenhoff</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>van der Bosch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mohrs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Omega-1, a glycoprotein secreted by <italic>Schistosoma mansoni</italic> eggs, drives Th2 responses</article-title>
          <source>J. Exp. Med.</source>
          <year>2009</year>
          <volume>206</volume>
          <fpage>1673</fpage>
          <lpage>1680</lpage>
          <pub-id pub-id-type="pmid">19635864</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinfelder</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Cannons</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Caspar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schwartzberg</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Sher</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jankovic</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1)</article-title>
          <source>J. Exp. Med.</source>
          <year>2009</year>
          <volume>206</volume>
          <fpage>1681</fpage>
          <lpage>1690</lpage>
          <pub-id pub-id-type="pmid">19635859</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Panjikar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Van Belle</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wyns</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Messens</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Loris</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Nonspecific base recognition mediated by water bridges and hydrophobic stacking in ribonuclease I from <italic>Escherichia coli</italic></article-title>
          <source>Protein Sci.</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>681</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="pmid">18305191</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loffler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Beintema</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Glund</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Phosphate-regulated induction of intracellular ribonucleases in cultured tomato (<italic>Lycopersicon esculentum</italic>) cells</article-title>
          <source>Plant Physiol.</source>
          <year>1992</year>
          <volume>98</volume>
          <fpage>1472</fpage>
          <lpage>1478</lpage>
          <pub-id pub-id-type="pmid">16668816</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nurnberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Glund</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Induction of an extracellular ribonuclease in cultured tomato cells upon phosphate starvation</article-title>
          <source>Plant Physiol.</source>
          <year>1990</year>
          <volume>92</volume>
          <fpage>970</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="pmid">16667413</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hillwig</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Contento</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ebany</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bassham</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Macintosh</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>RNS2, a conserved member of the RNase T2 family, is necessary for ribosomal RNA decay in plants</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2011</year>
          <volume>108</volume>
          <fpage>1093</fpage>
          <lpage>1098</lpage>
          <pub-id pub-id-type="pmid">21199950</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roiz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smirnoff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bar-Eli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shoseyov</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics</article-title>
          <source>Cancer</source>
          <year>2006</year>
          <volume>106</volume>
          <fpage>2295</fpage>
          <lpage>2308</lpage>
          <pub-id pub-id-type="pmid">16586499</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shoseyov</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Melnikova</surname>
              <given-names>VO</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leslie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roiz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smirnoff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Lev</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bar-Eli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis</article-title>
          <source>Cancer Res.</source>
          <year>2007</year>
          <volume>67</volume>
          <fpage>5258</fpage>
          <lpage>5266</lpage>
          <pub-id pub-id-type="pmid">17545605</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Acquati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Possati</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Campomenosi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Talevi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bardelli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Margiotta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bortoletto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rocchetti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tumor and metastasis suppression by the human RNASET2 gene</article-title>
          <source>Int. J. Oncol.</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>1159</fpage>
          <lpage>1168</lpage>
          <pub-id pub-id-type="pmid">15809705</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Acquati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Monti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lualdi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fabbri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sacco</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Gribaldo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Taramelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells</article-title>
          <source>Oncotarget</source>
          <year>2011</year>
          <volume>2</volume>
          <fpage>477</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">21646684</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luhtala</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>T2 Family ribonucleases: ancient enzymes with diverse roles</article-title>
          <source>Trends Biochem. Sci.</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>253</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="pmid">20189811</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kraetzner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gruene</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Grapp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gronborg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Urlaub</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asif</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>GÃ¤rtner</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis</article-title>
          <source>J. Biol. Chem.</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>3976</fpage>
          <lpage>3984</lpage>
          <pub-id pub-id-type="pmid">19038966</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deshpande</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Ribonucleases from T2 family</article-title>
          <source>Crit. Rev. Microbiol.</source>
          <year>2002</year>
          <volume>28</volume>
          <fpage>79</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">12109772</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabsch</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>XDS</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>125</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">20124692</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B18">
        <label>18</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>SADABSâBruker AXS area detector scaling and absorption correction, version. 2009/2001</article-title>
          <year>2009</year>
          <publisher-loc>Madison, WI</publisher-loc>
          <publisher-name>Bruker</publisher-name>
        </element-citation>
      </ref>
      <ref id="gks614-B19">
        <label>19</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>XPREPâBruker data preparation and reciprocal space exploration, version 2011/2011</article-title>
          <year>2011</year>
          <publisher-loc>Madison, WI</publisher-loc>
          <publisher-name>Bruker</publisher-name>
        </element-citation>
      </ref>
      <ref id="gks614-B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Inokuchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Koyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ohgi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Irie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of a plant ribonuclease, RNase LE</article-title>
          <source>J. Mol. Biol.</source>
          <year>2000</year>
          <volume>298</volume>
          <fpage>859</fpage>
          <lpage>873</lpage>
          <pub-id pub-id-type="pmid">10801354</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCoy</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Grosse-Kunstleve</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Winn</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Storoni</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Read</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Phaser crystallographic software</article-title>
          <source>J. Appl. Crystallogr.</source>
          <year>2007</year>
          <volume>40</volume>
          <fpage>658</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="pmid">19461840</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Experimental phasing with SHELXC/D/E:combining chain tracing with density modification</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>479</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="pmid">20383001</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emsley</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lohkamp</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Cowtan</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Features and development of Coot</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>486</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="pmid">20383002</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murshudov</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Vagin</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Dodson</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>1997</year>
          <volume>53</volume>
          <fpage>240</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">15299926</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Painter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Merritt</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Optimal description of a protein structure in terms of multiple groups undergoing TLS motion</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2006</year>
          <volume>62</volume>
          <fpage>439</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="pmid">16552146</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winn</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Isupov</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Murshudov</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Use of TLS parameters to model anisotropic displacements in macromolecular refinement</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>122</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">11134934</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chinea</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pons</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vriend</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Homology modelling, model and software evaluation: three related resources</article-title>
          <source>Bioinformatics</source>
          <year>1998</year>
          <volume>14</volume>
          <fpage>523</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="pmid">9694991</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>VB</given-names>
            </name>
            <name>
              <surname>Arendall</surname>
              <given-names>WB</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Headd</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Keedy</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Immormino</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Kapral</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title>
          <source>Acta. Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>12</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">20057044</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sheldrick</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>ANODE: ANOmalous and heavy-atom DEnsity calculation</article-title>
          <source>J. Appl. Crystallogr.</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>1285</fpage>
          <lpage>1287</lpage>
          <pub-id pub-id-type="pmid">22477786</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krissinel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Henrick</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2004</year>
          <volume>60</volume>
          <fpage>2256</fpage>
          <lpage>2268</lpage>
          <pub-id pub-id-type="pmid">15572779</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laskowski</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>PDBsum new things</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2009</year>
          <volume>37</volume>
          <fpage>D355</fpage>
          <lpage>D359</lpage>
          <pub-id pub-id-type="pmid">18996896</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ebert</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Robust recognition of zinc binding sites in proteins</article-title>
          <source>Protein Sci.</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>54</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">18042678</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mura</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>McCrimmon</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Vertrees</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sawaya</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>An introduction to biomolecular graphics</article-title>
          <source>PLoS Comput. Biol.</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>e1000918</fpage>
          <pub-id pub-id-type="pmid">20865174</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levitt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chothia</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Structural patterns in globular proteins</article-title>
          <source>Nature</source>
          <year>1976</year>
          <volume>261</volume>
          <fpage>552</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">934293</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Preparation and properties of RNase T2 immobilized on concanavalin A-sepharose</article-title>
          <source>Appl. Biochem. Biotechnol.</source>
          <year>1989</year>
          <volume>22</volume>
          <fpage>237</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="pmid">2596845</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uchida</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Purification and properties of RNase T2</article-title>
          <source>J. Biochem.</source>
          <year>1966</year>
          <volume>60</volume>
          <fpage>115</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">5968960</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Leeuw</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lanir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Roiz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smirnoff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shoseyov</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Almog</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The 1.8 A crystal structure of ACTIBIND suggests a mode of action for T2 ribonucleases as antitumorigenic agents</article-title>
          <source>J. Med. Chem.</source>
          <year>2012</year>
          <volume>55</volume>
          <fpage>1013</fpage>
          <lpage>1020</lpage>
          <pub-id pub-id-type="pmid">22216760</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakagawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Funatsu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of a ribonuclease from the seeds of bitter gourd (<italic>Momordica charantia</italic>) at 1.75 A resolution</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>1999</year>
          <volume>1433</volume>
          <fpage>253</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">10446375</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Numata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kakuta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Crystal structures of the ribonuclease MC1 mutants N71T and N71S in complex with 5â²-GMP: structural basis for alterations in substrate specificity</article-title>
          <source>Biochemistry</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>5270</fpage>
          <lpage>5278</lpage>
          <pub-id pub-id-type="pmid">12731868</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kakuta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Guanine binding site of the <italic>Nicotiana glutinosa</italic> ribonuclease NW revealed by X-ray crystallography</article-title>
          <source>Biochemistry</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>15195</fpage>
          <lpage>15202</lpage>
          <pub-id pub-id-type="pmid">12484757</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Numata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kikukawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Crystal structures of the ribonuclease MC1 from bitter gourd seeds, complexed with 2â²-UMP or 3â²-UMP, reveal structural basis for uridine specificity</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>572</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">10964705</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurihara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nonaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mitsui</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ohgi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Irie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>The crystal structure of ribonuclease Rh from <italic>Rhizopus niveus</italic> at 2.0 A resolution</article-title>
          <source>J. Mol. Biol.</source>
          <year>1996</year>
          <volume>255</volume>
          <fpage>310</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">8551522</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vidalino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Monti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Acquati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Taramelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Macchi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Intracellular trafficking of RNASET2, a novel component of P-bodies</article-title>
          <source>Biol. Cell</source>
          <year>2012</year>
          <volume>104</volume>
          <fpage>13</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">22188480</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinkel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Weatheritt</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Davey</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Van Roey</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Altenberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Toedt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Uyar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Budd</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ELMâthe database of eukaryotic linear motifs</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2012</year>
          <volume>40(Database issue)</volume>
          <fpage>D242</fpage>
          <lpage>D251</lpage>
          <pub-id pub-id-type="pmid">22110040</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wajant</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Scheurich</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>TNFR1-induced activation of the classical NF-kappaB pathway</article-title>
          <source>FEBS J.</source>
          <year>2011</year>
          <volume>278</volume>
          <fpage>862</fpage>
          <lpage>876</lpage>
          <pub-id pub-id-type="pmid">21232017</pub-id>
        </element-citation>
      </ref>
      <ref id="gks614-B46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bingman</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>GN</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Raines</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for catalysis by onconase</article-title>
          <source>J. Mol. Biol.</source>
          <year>2008</year>
          <volume>375</volume>
          <fpage>165</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">18001769</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>